NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
16.40
-0.57 (-3.36%)
At close: Dec 5, 2025, 4:00 PM EST
16.32
-0.08 (-0.49%)
After-hours: Dec 5, 2025, 7:22 PM EST
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $546.25 million as of December 5, 2025. Its market cap has increased by 99.36% in one year.
Market Cap
546.25M
Enterprise Value
557.41M
1-Year Change
99.36%
Ranking
Category
Stock Price
$16.40
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $546.25M, an increase of 38.90%. That is a compound annual growth rate of 7.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 546.25M | 63.55% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |